glutathione therapy for parkinson' Revamping Parkinson's disease using PLGA-based drug delivery systems Glutathione and neurodegenerative diseases: immunopharmacological

Gut Microbes (2021) 13(1):1949096

Modern immunosuppressive medications are highly effective at curbing bouts of inflammation, but have surprisingly limited effectiveness on disease progression

Moreover, dihydropyridine compounds with good central nervous system (CNS) penetration, such as nimodipine showed promising mood stabilizing effects in humans with affective disorders, suggesting that LTCC antagonists represent an additional option in the pharmacotherapy of psychiatric diseases, and especially patients carrying the CACNA1C risk SNP could benefit from this alternative treatment strategy 13,43,52

Another advantage is that the -galactosidase enzyme is present only in the lysosome, whereas -glucuronidase is expressed in lysosomes and also in the microenvironment of solid tumors

Notify your doctor if you take multiple blood pressure medications as dosages may need reduction to avoid hypotension

PubChem PubChem entry for SLU-PP-332 (CAS 303760-60-3)